Controversies in Precision Medicine

The Summit, under the leadership of Professor Dan Peer , Director of Tel Aviv University Cancer Biology Research Center, will explore the provocative scientific debates on Precision Medicine and facilitate discussions on future ways to increase the productivity of biopharmaceutical and clinical innovation.

This year’s summit is titled, “Where do we stand in drug development?” to create a focused environment for quality and sincere scientific debate on the value and direction of the industry. Through engaging panels, roundtable discussions, break-out sessions and interactive architecture the event is designed to provide the participants with exciting opportunities to ignite solutions, network and innovate.

150+ senior level attendees from leading industry companies, academia and government institutions have put innovation in their pipeline.